Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Treasury Shares (2019 - 2025)

Historic Treasury Shares for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $3.7 million.

  • Pulmonx's Treasury Shares rose 2613.28% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 2613.28%. This contributed to the annual value of $2.7 million for FY2024, which is 2154.64% up from last year.
  • Latest data reveals that Pulmonx reported Treasury Shares of $3.7 million as of Q3 2025, which was up 2613.28% from $4.1 million recorded in Q2 2025.
  • Pulmonx's 5-year Treasury Shares high stood at $4.3 million for Q1 2025, and its period low was $12945.0 during Q1 2021.
  • Moreover, its 5-year median value for Treasury Shares was $2.6 million (2023), whereas its average is $2.2 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 12568.03% in 2022, then surged by 2154.64% in 2024.
  • Pulmonx's Treasury Shares (Quarter) stood at $442428.0 in 2021, then soared by 125.68% to $998473.0 in 2022, then skyrocketed by 124.83% to $2.2 million in 2023, then rose by 21.55% to $2.7 million in 2024, then skyrocketed by 36.78% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $4.1 million for Q2 2025, and $4.3 million during Q1 2025.